12142017Headline:

New York City, New York

HomeNew YorkNew York City

Email Staff Writer Staff Writer on LinkedIn Staff Writer on Twitter Staff Writer on Facebook
Staff Writer
Staff Writer
Contributor •

FDA Warns of Cancer Risk with Elidel and Protopic

Comments Off

Last week, the FDA approved two new warnings on the labeling for two skin care drugs, Elidel and Protopic. Although a causal link between these two topical drugs and certain cancers has not yet been established, patients receiving these drugs have reported a higher incidence of cancers, namely skin cancer and lymphoma.

Patients taking these drugs are encouraged to consult with their doctor to determine the proper and safe use of Elidel and Protopic.